HCI Group, Inc. (FRA:0H5)

Intra-Cellular Therapies Revenue

HCI Group had revenue of $216.43M USD in the quarter ending March 31, 2025, with 4.75% growth. This brings the company's revenue in the last twelve months to $759.87M, up 20.95% year-over-year. In the year 2024, HCI Group had annual revenue of $750.05M with 36.21% growth.

• Revenue (ttm): $759.87M
• Revenue Growth: +20.95%
• P/S Ratio: 1.98
• Revenue / Employee: $1.38M
• Employees: 552
• Market Cap: 1.39B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	750.05M	199.38M	36.21%
Dec 31, 2023	550.67M	54.22M	10.92%
Dec 31, 2022	496.45M	88.53M	21.70%
Dec 31, 2021	407.92M	134.45M	49.16%
Dec 31, 2020	273.47M	30.99M	12.78%